Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Bentley

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Leukemia Research|January 1, 1991
In vitro chemosensitivity testing in chronic lymphocytic leukaemia patientsJ A Hanson, D P Bentley, E A Bean, et al.
British Medical Journal (Clinical Research Ed.)|January 21, 1984
Monitoring effects of oral anticoagulants during treatment with heparinP Thomas, A Fennerty, G Backhouse, et al.
Clinical and Laboratory Haematology|January 1, 1988
A cluster of three cases of aplastic anaemia in childrenG J Morgan, S R Palmer, D Onions, et al.
Leukemia|March 1, 1990
Is the mdr 1 gene relevant in chronic lymphocytic leukemia?J A Holmes, A Jacobs, G Carter, et al.
Thrombosis and Haemostasis|February 19, 1990
Lipids and warfarin requirementsA Robinson, F O Liau, P A Routledge, et al.
British Medical Journal (Clinical Research Ed.)|March 1, 1986
Guidelines to control heparin treatmentA G Fennerty, S Renowden, N Scolding, et al.
British Medical Journal (Clinical Research Ed.)|April 28, 1984
Flexible induction dose regimen for warfarin and prediction of maintenance doseA Fennerty, J Dolben, P Thomas, et al.
Clinical and Laboratory Haematology|January 1, 1987
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolismA G Fennerty, J Dolben, P Thomas, et al.
Leukemia Research|January 1, 1988
Aplastic anaemia incidence in parts of the United Kingdom in 1985R A Cartwright, P A McKinney, L Williams, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Leukemia Research|January 1, 1991
In vitro chemosensitivity testing in chronic lymphocytic leukaemia patientsJ A Hanson, D P Bentley, E A Bean, et al.
British Medical Journal (Clinical Research Ed.)|January 21, 1984
Monitoring effects of oral anticoagulants during treatment with heparinP Thomas, A Fennerty, G Backhouse, et al.
Clinical and Laboratory Haematology|January 1, 1988
A cluster of three cases of aplastic anaemia in childrenG J Morgan, S R Palmer, D Onions, et al.
Leukemia|March 1, 1990
Is the mdr 1 gene relevant in chronic lymphocytic leukemia?J A Holmes, A Jacobs, G Carter, et al.
Thrombosis and Haemostasis|February 19, 1990
Lipids and warfarin requirementsA Robinson, F O Liau, P A Routledge, et al.
British Medical Journal (Clinical Research Ed.)|March 1, 1986
Guidelines to control heparin treatmentA G Fennerty, S Renowden, N Scolding, et al.
British Medical Journal (Clinical Research Ed.)|April 28, 1984
Flexible induction dose regimen for warfarin and prediction of maintenance doseA Fennerty, J Dolben, P Thomas, et al.
Clinical and Laboratory Haematology|January 1, 1987
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolismA G Fennerty, J Dolben, P Thomas, et al.
Leukemia Research|January 1, 1988
Aplastic anaemia incidence in parts of the United Kingdom in 1985R A Cartwright, P A McKinney, L Williams, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Pageof 5